Magic mushroom therapy gets second shot at easing cancer anxiety

NCT ID NCT06644170

Summary

This small, early-stage study tested whether a second round of psilocybin-assisted group therapy is safe and helpful for people with advanced cancer who still have significant anxiety after a first session. Fifteen participants with metastatic cancer received psilocybin in a controlled group retreat setting, supported by preparation and follow-up therapy sessions. The main goal was to check for safety and side effects, while also seeing if this second experience could further reduce anxiety and distress.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEMATOPOIETIC AND LYMPHATIC SYSTEM NEOPLASM are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Fred Hutch/University of Washington Cancer Consortium

    Seattle, Washington, 98109, United States

Conditions

Explore the condition pages connected to this study.